The House Energy and Commerce Committee Health Subcommittee met this week to discuss reauthorization of the Animal Drug User Fee Act (ADUFA) and the Animal Generic Drug User Fee Amendments (AGDUFA).
Set to expire Sept. 30, both grant the U.S. Food and Drug Administration permission to collect fees from the makers of new animal drugs, including generic animal drugs, which are used to support the agency’s approval and market introduction programs. Senate and House bipartisan draft reauthorization legislation includes a requirement that all requests for new animal drugs be submitted electronically beginning Oct. 1. Dr. Steven Solomon, director of FDA’s Center for Veterinary Medicine, testified before the subcommittee and affirmed the agency’s objective to work with Congress to advance the legislation.
NPPC supports the reauthorization of ADUFA and AGDUFA, which are crucial for ensuring that animal health, human health and food safety are protected. Failure to renew the laws by the deadline will result in a major disruption for the livestock production industry.